4//SEC Filing
Tourangeau Greg 4
Accession 0000950170-24-028827
CIK 0001680581other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 6:05 PM ET
Size
5.1 KB
Accession
0000950170-24-028827
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Sale
Common Stock
2024-03-08$11.72/sh−4,884$57,219→ 11,807 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.74, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]Includes 699 shares acquired under the Issuer's employee stock purchase plan on May 13, 2022.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001916566
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 6:05 PM ET
- Size
- 5.1 KB